Cigna revenue
Cigna's revenue was $274.90bn in fiscal 2025, up 11.2% on the year before. Since fiscal 2016 ($39.84bn) it has grown at a compound 23.9% a year. Over the last twelve months it was $282.38bn.
Revenue history
| Fiscal year | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39.8 | 41.8 | 48.7 | 153.6 | 160.4 | 174.1 | 180.5 | 195.3 | 247.1 | 274.9 | 282.4 |
| Growth on the year before | — | +4.9% | +16.4% | +215.7% | +4.5% | +8.5% | +3.7% | +8.2% | +26.6% | +11.2% | — |
| Gross profit | 37.4 | 39.4 | 43.9 | 55.9 | 56.9 | 56.5 | 55.7 | 61.5 | 64.6 | 59.9 | 58.3 |
| Gross margin | 93.8% | 94.1% | 90.1% | 36.4% | 35.5% | 32.5% | 30.8% | 31.5% | 26.1% | 21.8% | 20.6% |
Where the revenue comes from
| Line of business | Revenue | YoY |
|---|---|---|
| Products | $217B | ▲ 16.9% |
| Services | $16.9B | ▲ 14.4% |
| Service Fees and Other Revenues | $16.9B | ▲ 14.4% |
| Other services | $696M | ▲ 19.2% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Cigna's 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Cigna | $282.38bn | 7.8% | 14.9% |
| CVS Health | $415.09bn | 7.4% | 7.0% |
| Brightspring Health Services, Inc. | $15.25bn | 35.9% | — |
| Labcorp | $14.59bn | 6.0% | 6.6% |
| DaVita | $14.17bn | 6.4% | 6.0% |
| Quest Diagnostics | $11.84bn | 9.1% | 8.4% |
Compare with peers
- CVS Health revenue
- Brightspring Health Services, Inc. revenue
- Labcorp revenue
- DaVita revenue
- Quest Diagnostics revenue
Head to head: CI vs CVSBTSG vs CICI vs LH
More: Health Care Services stocks compared, Health Care sector, rankings of US companies